Canaccord Genuity Group Reiterates C$15.00 Price Target for Vitalhub (TSE:VHI)

Vitalhub (TSE:VHI) has been assigned a C$15.00 price target by investment analysts at Canaccord Genuity Group in a note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 70.26% from the stock’s previous close.

Separately, National Bank Financial dropped their price objective on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a research report on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of C$13.00.

Vitalhub Price Performance

TSE:VHI traded up C$0.20 during mid-day trading on Friday, reaching C$8.81. The stock had a trading volume of 247,513 shares, compared to its average volume of 334,529. Vitalhub has a 12 month low of C$6.46 and a 12 month high of C$12.72. The stock has a market capitalization of C$558.02 million, a PE ratio of 73.42, a P/E/G ratio of 1.18 and a beta of 0.91. The stock has a 50-day simple moving average of C$7.33 and a two-hundred day simple moving average of C$7.50.

Vitalhub (TSE:VHI) last released its earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. Vitalhub had a return on equity of 2.79% and a net margin of 5.89%.The firm had revenue of C$31.74 million during the quarter. Equities analysts expect that Vitalhub will post 0.2296467 EPS for the current year.

About Vitalhub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.